phone icon(716) 674-6030 fax icon(716) 674-6052
bill pay iconPay Your Bill
Receive our Health e-Newsletter
  Home  
  Our Team  
  Patient Info  
  Services  
   
  Patient Info  

News for Healthier Living

Multi-Omics Joint Analysis Revealed the Metabolic Profile of Retroperitoneal Liposarcoma

This paper reveals the metabolic profile of retroperitoneal liposarcoma via proteomic, metabolomic, and lipidomic analyses, showing upregulated glycolysis and downregulated TCA cycle, and finds that glycolytic and PPP inhibitors enhance MDM2 and CDK4 inhibitors' antitumor effects, suggesting therapeutic strategies.

October 31, 2025


November 5 2025

November 4 2025

November 3 2025

November 2 2025

November 1 2025

October 31 2025

October 30 2025

October 29 2025

October 28 2025

October 27 2025

October 26 2025

October 25 2025

October 24 2025

October 23 2025

October 22 2025